Taysha stops developing a gene therapy amid debate over FDA's stance on ultra-rare trials - Endpoints News endpts.com Submitted by endpointsnews6292 on September 20, 2023 at 3:07 PM in business No comments 14
Lonza CEO Pierre-Alain Ruffieux to leave CDMO amid reduced growth - Endpoints News endpts.com Submitted by endpointsnews6292 on September 18, 2023 at 8:27 AM in business No comments 44
Moderna cuts four programs in vaccines, solid tumors and heart failure as it increases, prioritizes pipeline - Endpoints News endpts.com Submitted by endpointsnews6292 on September 14, 2023 at 11:04 AM in business No comments 7
Flagship's AI unicorn Generate raises $273M Series C, as first drug in 17-program pipeline enters the clinic - Endpoints News endpts.com Submitted by endpointsnews6292 on September 14, 2023 at 10:00 AM in business No comments 48
FDA adcomm votes in favor of Alnylam's new indication for Onpattro - Endpoints News endpts.com Submitted by endpointsnews6292 on September 13, 2023 at 8:15 PM in business No comments 55
Rocket Pharmaceuticals says FDA agrees to 12-patient study for accelerated approval, expects to raise $175M - Endpoints News endpts.com Submitted by endpointsnews6292 on September 13, 2023 at 3:21 PM in business No comments 27
Neumora, RayzeBio look to each raise $200M+ in IPOs - Endpoints News endpts.com Submitted by endpointsnews6292 on September 11, 2023 at 3:17 PM in business No comments 31
Moderna strikes $1.8B cancer research deal with Immatics - Endpoints News endpts.com Submitted by endpointsnews6292 on September 11, 2023 at 11:39 AM in business No comments 32
NASH company Madrigal names former Sanofi exec Bill Sibold as new CEO - Endpoints News endpts.com Submitted by endpointsnews6292 on September 11, 2023 at 11:29 AM in business No comments 36
Gilead, AstraZeneca/Daiichi Sankyo present mid-stage data on rival TROP2 antibody-drug conjugates - Endpoints News endpts.com Submitted by endpointsnews6292 on September 11, 2023 at 11:20 AM in business No comments 27
MIT scientists tweak mRNA Covid jabs to be ‘self-adjuvanting’ - Endpoints News endpts.com Submitted by endpointsnews6292 on September 8, 2023 at 3:35 PM in health No comments 4
Verge Genomics teams up with AstraZeneca in drug discovery deal - Endpoints News endpts.com Submitted by endpointsnews6292 on September 8, 2023 at 11:00 AM in business No comments 28
AstraZeneca’s Ultomiris hit with CRL in NMOSD due to issues with risk mitigation strategy - Endpoints News endpts.com Submitted by endpointsnews6292 on September 6, 2023 at 9:48 AM in business No comments 28
Roche publishes PhI data for KRAS drug in NEJM paper as it chases Amgen, Mirati - Endpoints News endpts.com Submitted by endpointsnews6292 on August 24, 2023 at 11:08 AM in business No comments 42
J&J to close its Leiden vaccine unit following wider infectious disease cuts - Endpoints News endpts.com Submitted by endpointsnews6292 on August 23, 2023 at 3:19 PM in business No comments 36
Pfizer expects fewer people needed for Lyme disease vaccine trial - Endpoints News endpts.com Submitted by endpointsnews6292 on August 23, 2023 at 2:58 PM in health No comments 1
FDA puts partial hold on Gilead's CD47 hopeful in AML - Endpoints News endpts.com Submitted by endpointsnews6292 on August 21, 2023 at 3:12 PM in business No comments 58
Genesis Therapeutics raises $200M for AI drug discovery based on Stanford research - Endpoints News endpts.com Submitted by endpointsnews6292 on August 21, 2023 at 12:00 PM in business No comments 59
Moderna and CARsgen team up on CAR-T cell therapy and mRNA cancer vaccine combo - Endpoints News endpts.com Submitted by endpointsnews6292 on August 21, 2023 at 11:17 AM in business No comments 61
FDA approves Regeneron's antibody for rare immune disease, resolves manufacturing issues for aflibercept - Endpoints News endpts.com Submitted by endpointsnews6292 on August 18, 2023 at 6:11 PM in business No comments 25
Moderna's updated Covid vaccine likely provides protection against new variants, but uptake remains uncertain - Endpoints News endpts.com Submitted by endpointsnews6292 on August 18, 2023 at 3:05 PM in business No comments 44
Sanofi bid first, but Biogen won out in fight to acquire Reata — report - Endpoints News endpts.com Submitted by endpointsnews6292 on August 16, 2023 at 11:34 AM in business No comments 24
Updated: EQRx sells itself to another Alexis Borisy company, Revolution Medicines, in all-stock deal - Endpoints News endpts.com Submitted by endpointsnews6292 on August 1, 2023 at 11:36 AM in business No comments 57
AstraZeneca picks up Pfizer's rare disease gene therapies, taps new R&D leader as Mene Pangalos steps down - Endpoints News endpts.com Submitted by endpointsnews6292 on July 28, 2023 at 9:50 AM in business No comments 30
Revlimid losses lead Bristol Myers Squibb to lower full-year guidance - Endpoints News endpts.com Submitted by endpointsnews6292 on July 27, 2023 at 6:40 PM in business No comments 2